medigraphic.com
Órgano Oficial del Hospital Angeles Health System

2018, Número 4

<< Anterior Siguiente >>

Acta Med 2018; 16 (4)


Lupus eritematoso sistémico en el embarazo

Stuht LD, Santoyo HS, Lara BI

Idioma: Español
Referencias bibliográficas: 49
Paginas: 331-338
Archivo PDF: 147.37 Kb.


RESUMEN

El lupus eritematoso sistémico (LES) es una enfermedad crónica, multisistémica que se caracteriza por una respuesta autoinmune aberrante a autoantígenos con afección a cualquier órgano o tejido, que afecta principalmente a mujeres en edad reproductiva. LES afecta aproximadamente a 300,000 personas en los Estados Unidos de América con relación mujer:hombre de 10:1. El objetivo de este artículo es revisar los principales riesgos asociados al embarazo de pacientes con LES, así como las recomendaciones generales en cuanto al periodo preconcepcional, el manejo general y farmacológico durante el embarazo y la lactancia.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Golder V, Hoi A. Systemic lupus erythematosus: an update. Med J Aust. 2017; 206 (5): 215-220.

  2. Paglia G, Leone M, Lepri G. One year in review 2017: systemic lupus erythematosus. Clin Exp Rheumatol. 2017; 35: 551-561.

  3. Vu Lam NC, Ghetu M, Bieniek M. Systemic lupus erythematosus: primary care approach to diagnosis and management. Am Fam Physician. 2016; 94 (4): 284-294.

  4. Tsokos G. Systemic lupus erythematosus. NEJM. 2011; 365: 2110-2121.

  5. Nucamendi C. Boletín epidemiológico (Sistema Nacional de Vigilancia Epidemiológico, Sistema Único de información): ¿Qué es el lupus eritematoso? México, 2013. Recuperado de: https://www.gob.mx/cms/uploads/attachment/file/13761/2013_30.pdf.

  6. Centro Estatal de Vigilancia Epidemiológica y Control de Enfermedades (2017). Lo que debes de saber del lupus. Estado de México. Recuperado de: http://salud.edomex.gob.mx/cevece/documentos/difusion/tripticos/2017/Semana%2019.pdf.

  7. Doria A, Laccarino L, Arienti S et al. Th2 immune deviation induced by pregnancy: the two faces of autoimmune rheumatic diseases. Reprod Toxicol. 2006; 22: 234-241.

  8. Narcés-Torices MA, Hernández-Pacheco JA, Estrada-Altamirano A y cols. Lupus eritematoso sistémico activo durante el embarazo, curso clínico y pronóstico en una Unidad de Cuidados Intensivos. Perinatol Reprod Hum. 2012; 26 (2): 96-105.

  9. Molad Y, Brokowski T, Monselise A et al. Maternal and fetal outcome of lupus pregnancy: a prospective study of 29 pregnancies. Lupus. 2005; 14: 145-151.

  10. Kroese S, Abheiden C, Blomjoues B et al. Maternal and perinatal outcome in women with systemic lupus erythematosus: a retrospective bicenter cohort study. J Immunol. 2013; 2017: 1-9.

  11. Bundhun PK, Soogund MZ, Huang F. Impact of systemic lupus erythematosus on maternal and fetal outcomes following pregnancy: a meta-analysis of studies published between years 2001-2016. J Autoimmun. 2017; 79: 17-27.

  12. Saavedra MA, Miranda-Hernández D, Sánchez A et al. Pregnancy outcomes in women with childhood-onset
and adult-onset systemic lupus erythematosus: a comparative study. Rheumatol Int. 2016; 36: 1431-1437.

  13. Zhan Z, Yang Y, Zhan Y et al. Fetal outcomes and associated factors of adverse outcomes of pregnancy in southern Chinese women with systemic lupus erythematosus. PLoS ONE. 2017; 12 (4): e0176457. https://doi.org/10.1371/journal.pone.0176457.

  14. Phansenee S, Sekararithi R, Jatavan P et al. Pregnancy outcomes among women with systemic lupus erythematosus: a retrospective cohort study from Thailand. Lupus. 2018; 27: 158-164.

  15. Farfan-Labonne B, Luis-Vásquez I, Ávila-Carrasco A y cols. Resultados perinatales en mujeres mexicanas con lupus eritematoso sistémico. Perinatol Reprod Hum. 2017; 31 (1): 3-9.

  16. Doria A, Tincani A, Lockshin M. Challenges of lupus pregnancies. Rheumatology. 2008; 47: iii9-iii12.

  17. Andreoli L, Bertsias GK, Agmon-Levin N et al. EULAR recommendations for women’s health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome. Ann Rheum Dis. 2017; 76 (3): 476-485. doi: 10.1136/annrheumdis-2016-209770.

  18. Ruiz-Irastorza G, Khamashta MA. Lupus and pregnancy: ten questions and some answers. Lupus. 2008; 17 (5): 416-420.

  19. Marder W, Littlejohn E, Somers E. Pregnancy and autoimmune connective tissue diseases. Best Pract Res Clin Rheumatol. 2016; 30 (1): 63-80.

  20. Ruiz-Irastorza G, Khamashta MA. Lupus and pregnancy: integrating clues from the bench and bedside. Eur J Clin Invest. 2010; 41 (6): 672-678.

  21. Saavedra MA, Barrera A, Cabral A y cols. Guías de práctica clínica para la atención del embarazo en mujeres con enfermedades reumáticas autoinmunes del Colegio Mexicano de Reumatología. Parte 1. Reumatol Clin. 2015; 11 (5): 295-304.

  22. Oktem O, Yagmur H, Bengisu H, Urman B. Reproductive aspects of systemic lupus erythematosus. J Reprod Immunol. 2016; 117: 57-65.

  23. Khamashta MA. Systemic lupus erythematosus and pregnancy. Best Pract Res Clin Rheumatol. 2006; 20: 685-694.

  24. Lockshin MD, Sammaritano LR. Lupus pregnancy. Autoimmunity. 2003; 36 (1): 33-40.

  25. Andreoli L, Crisafulli F, Tincani A. Pregnancy and reproductive aspects of systemic lupus erythematous. Curr Opin Rheumatol. 2017; 29: 473-479.

  26. Erkan D, Sammaritano L. New insights into pregnancy-related complications in systemic lupus erythematosus. Curr Rheumatol Rep. 2003; 5: 357-363.

  27. Izmirly PM, Rivera TL, Buyon JP. Neonatal lupus syndromes. Rheum Dis Clin North Am. 2007; 33: 267-285.

  28. Al-Janadi M, al-Balla S, al-Dalaan A, Raziuddin S. Cytokine profile in systemic lupus erythematosus, rheumatoid arthritis and other rheumatic disease. J Clin Immunol. 1993; 13: 58-67.

  29. Diehl S, Rincon M. The two faces of IL-6 on Th1/Th2 differentiation. Mol Immunol. 2002; 39: 531-536.

  30. Petri M. Sex hormones and systemic lupus erythematosus. Lupus. 2008; 17: 412-415.

  31. González L, Restrepo M. Lupus eritematoso sistémico y embarazo. Rev Col Reumatol. 2011; 18 (3): 175-186.

  32. Kattah A, Garovic V. Pregnancy and lupus nephritis. Sem Nephrol. 2015; 35 (5): 487-499.

  33. Lightstone L, Hladunewich M. Lupus nephritis and pregnancy: concerns and management. Sem Nephrol. 2017; 37 (49): 347-353.

  34. Jara L, Medina G, Cruz-Dominguez P et al. Risk factors of systemic lupus erythematosus flares during pregnancy. Immunol Res. 2014; 60 (2-3): 184-192.

  35. Moroni G, Ponticelli C. Pregnancy in women with systemic lupus erythematosus (SLE). Eur J Intern Med. 2016; 32: 7-12.

  36. Barbhaiya M, Bermas B. Evaluation and management of systemic lupus erythematosus and rheumatoid arthritis during pregnancy. Clin Immunol. 2013; 149 (2): 225-235.

  37. Clowse ME, Magder L, Witter F et al. Hydroxychloroquine in lupus pregnancy. Arthritis Rheum. 2006; 54: 3640-3647.

  38. Leroux M, Desveaux C, Parcevaux M et al. Impact of hydroxychloroquine on preterm delivery and intrauterine growth restriction in pregnant women with systemic lupus erythematosus: a descriptive 
cohort study. Lupus. 2015; 24: 1384-1391.

  39. Ugarte A, Villar I, Ruiz-Irastorza G. Manejo del embarazo en pacientes con lupus eritematoso sistémico. Rev Clin Esp. 2012; 212 (10): 491-498.

  40. Baer AN, Witter FR, Petri M. Lupus and pregnancy. Obstet Gynecol Surv. 2011; 66: 639-653.

  41. Sammaritano L. Management of systemic lupus erythematosus during pregnancy. Annu Rev Med. 2017; 68: 271-285.

  42. Petri M. The Hopkins lupus pregnancy center: ten keys issues in management. Rheum Dis Clin North Am. 2007; 33 (2): 227-235.

  43. Lateef A, Petri M. Managing lupus patients during pregnancy. Best Pract Res Clin Rheumatol. 2013; 27 (3): 435-447.

  44. Ostensen M, Khamashta M, Lockshin M, Parke A, Brucato A, Carp H et al. Anti-inflammatory and immunosuppressive drugs and reproduction. Arthritis Research & Therapy. 2006; 8 (3): 209.

  45. Ruiz-Irastorza G, Lima F, Alves J, Khamashta MA, Simpson J, Hughes GR et al. Increased rate of lupus flare during pregnancy and the puerperium: A prospective study of 78 pregnancies. Br J Rheumatol. 1996; 35: 133-138.

  46. Webster P, Wardle A, Bramham K et al. Tacrolimus is an effective treatment for lupus nephritis in pregnancy. Lupus. 2014; 23: 1192-1196.

  47. Perricone R, de Carolis C, Kröegler B et al. Intravenous immunoglobulin therapy in pregnant patients affected with systemic lupus erythematosus and recurrent spontaneous abortion. Rheumatol. 2008; 47: 646-651.

  48. World Health Organization. Breastfeeding health topic. [Accessed on 12 March 2018] Available at: http://www.who.int/topics/breastfeeding/es.

  49. Acevedo M, Petrini J, Micelli M et al. Breastfeeding initiation, duration, and reasons for weaning in patients with systemic lupus erythematosus. Rheumatol Int. 2017; 37: 1183-1186.




2020     |     www.medigraphic.com